GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Scivision Biotech Inc (TPE:1786) » Definitions » Effective Interest Rate on Debt %

Scivision Biotech (TPE:1786) Effective Interest Rate on Debt % : 2.27% (As of Sep. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Scivision Biotech Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Scivision Biotech's annualized positive value of Interest Expense for the quarter that ended in Sep. 2024 was NT$4.4 Mil. Scivision Biotech's average total debt for the quarter that ended in Sep. 2024 was NT$194.9 Mil. Therefore, Scivision Biotech's annualized Effective Interest Rate on Debt % for the quarter that ended in Sep. 2024 was 2.27%.


Scivision Biotech Effective Interest Rate on Debt % Historical Data

The historical data trend for Scivision Biotech's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Scivision Biotech Effective Interest Rate on Debt % Chart

Scivision Biotech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Effective Interest Rate on Debt %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.70 2.34 1.68 1.23 2.15

Scivision Biotech Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Effective Interest Rate on Debt % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.16 2.10 2.16 1.93 2.27

Competitive Comparison of Scivision Biotech's Effective Interest Rate on Debt %

For the Medical Instruments & Supplies subindustry, Scivision Biotech's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Scivision Biotech's Effective Interest Rate on Debt % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Scivision Biotech's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Scivision Biotech's Effective Interest Rate on Debt % falls into.



Scivision Biotech Effective Interest Rate on Debt % Calculation

Scivision Biotech's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Dec. 2023 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (A: Dec. 2022 )+Total Debt  (A: Dec. 2023 ))/ count )
=-1  *  -8.22/( (416.05+347.913)/ 2 )
=-1  *  -8.22/381.9815
=2.15 %

where

Total Debt  (A: Dec. 2022 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=410.79 + 5.26
=416.05

Total Debt  (A: Dec. 2023 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=346.697 + 1.216
=347.913

Scivision Biotech's annualized Effective Interest Rate on Debt % for the quarter that ended in Sep. 2024 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (Q: Jun. 2024 )+Total Debt  (Q: Sep. 2024 ))/ count )
=-1  *  -4.424/( (229.588+160.158)/ 2 )
=-1  *  -4.424/194.873
=2.27 %

where

Total Debt  (Q: Jun. 2024 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=228.394 + 1.194
=229.588

Total Debt  (Q: Sep. 2024 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=158.973 + 1.185
=160.158

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (Sep. 2024) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.


Scivision Biotech  (TPE:1786) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.


Scivision Biotech Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of Scivision Biotech's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.


Scivision Biotech Business Description

Traded in Other Exchanges
N/A
Address
No. 1, South 1st Road, KEPZ, Kaohsiung, TWN, 806
Scivision Biotech Inc is engaged in the manufacturing and distribution of hyaluronic acid medical supplies in Taiwan. It offers medical devices, including absorbable adhesion barriers, dermal implants, synovial fluid supplements, and intravesical instillation.

Scivision Biotech Headlines

No Headlines